Teva 'disappointed' by Irish consultants' boycott of its pharmaceuticals, company tells 'Post'

Teva Pharmaceuticals expressed disappointment over the Irish Hospital Consultants Association's decision to boycott its products, citing ethical concerns over Israel's actions in Gaza. The motion encourages members to avoid prescribing Teva medicines where equivalent alternatives exist. Teva stated healthcare should not be politicized and remains committed to Irish patients.

Teva Pharmaceuticals has expressed disappointment over the Irish Hospital Consultants Association's (IHCA) decision to boycott its products, the company told The Jerusalem Post on Sunday. The IHCA passed a motion last week encouraging members to avoid prescribing, administering, or using Teva products where clinically appropriate and equivalent alternatives are available, as long as it does not compromise patient safety or clinical outcomes. A full prescription boycott would affect 12.5% of all prescriptions in Ireland, the amount estimated to be produced by Teva. The motion cited 'significant ethical concern and international scrutiny' over Israel's actions in Gaza. Teva responded that 'healthcare shouldn't be politicized' and that it remains committed to working with Irish healthcare professionals. The motion was proposed by pediatric orthopedic surgeon Thomas Donnelly, who said he 'cannot in good conscience use Teva Pharmaceuticals products' after treating families from Gaza with devastating injuries. Separately, the UK's Royal College of Nursing and Royal College of Pharmacy recently cut commercial ties with Teva UK, though they did not boycott products.